vs
太平洋生物科学（ASMB）与Forian Inc.（FORA）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是Forian Inc.的1.4倍（$10.8M vs $8.0M），Forian Inc.净利率更高（-22.9% vs -85.2%，领先62.4%），太平洋生物科学同比增速更快（57.6% vs 37.0%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Forian Inc是一家专注于医疗健康领域的数据分析与技术服务商，提供SaaS模式的真实世界证据解决方案、临床决策支持工具及运营优化服务，客户覆盖生物制药企业、医疗机构及生命科学领域相关机构，助力提升诊疗效率、推动医学研究进展。
ASMB vs FORA — 直观对比
营收规模更大
ASMB
是对方的1.4倍
$8.0M
营收增速更快
ASMB
高出20.6%
37.0%
净利率更高
FORA
高出62.4%
-85.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $8.0M |
| 净利润 | $-9.2M | $-1.8M |
| 毛利率 | — | 49.2% |
| 营业利润率 | -100.9% | -24.4% |
| 净利率 | -85.2% | -22.9% |
| 营收同比 | 57.6% | 37.0% |
| 净利润同比 | 4.3% | -1012.2% |
| 每股收益（稀释后） | $-0.72 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBFORA
| Q4 25 | — | $8.0M | ||
| Q3 25 | $10.8M | $7.8M | ||
| Q2 25 | $9.6M | $7.5M | ||
| Q1 25 | $9.4M | $7.1M | ||
| Q4 24 | $7.4M | $5.8M | ||
| Q3 24 | $6.8M | $4.7M | ||
| Q2 24 | $8.5M | $4.8M | ||
| Q1 24 | $5.8M | $4.9M |
净利润ASMBFORA
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-9.2M | $-151.2K | ||
| Q2 25 | $-10.2M | $224.8K | ||
| Q1 25 | $-8.8M | $-1.1M | ||
| Q4 24 | — | $199.7K | ||
| Q3 24 | $-9.6M | $-204.9K | ||
| Q2 24 | $-11.2M | $-2.6M | ||
| Q1 24 | $-9.1M | $-1.2M |
毛利率ASMBFORA
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 51.6% | ||
| Q2 25 | — | 56.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 58.3% | ||
| Q3 24 | — | 70.1% | ||
| Q2 24 | — | 62.2% | ||
| Q1 24 | — | 65.1% |
营业利润率ASMBFORA
| Q4 25 | — | -24.4% | ||
| Q3 25 | -100.9% | -6.1% | ||
| Q2 25 | -115.2% | 0.6% | ||
| Q1 25 | -105.5% | -19.8% | ||
| Q4 24 | — | -24.9% | ||
| Q3 24 | -160.1% | -17.0% | ||
| Q2 24 | -143.0% | -62.2% | ||
| Q1 24 | -185.5% | -36.3% |
净利率ASMBFORA
| Q4 25 | — | -22.9% | ||
| Q3 25 | -85.2% | -1.9% | ||
| Q2 25 | -105.9% | 3.0% | ||
| Q1 25 | -93.6% | -16.0% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | -140.4% | -4.4% | ||
| Q2 24 | -130.7% | -53.4% | ||
| Q1 24 | -156.9% | -24.9% |
每股收益（稀释后）ASMBFORA
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $-0.72 | $0.00 | ||
| Q2 25 | $-1.33 | $0.01 | ||
| Q1 25 | $-1.17 | $-0.04 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-1.51 | $-0.01 | ||
| Q2 24 | $-1.98 | $-0.08 | ||
| Q1 24 | $-1.66 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $31.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $29.8M |
| 总资产 | $240.0M | $44.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBFORA
| Q4 25 | — | $31.6M | ||
| Q3 25 | $22.5M | $28.2M | ||
| Q2 25 | $24.0M | $35.6M | ||
| Q1 25 | $23.4M | $35.7M | ||
| Q4 24 | $38.3M | $35.1M | ||
| Q3 24 | $28.5M | $49.4M | ||
| Q2 24 | $19.2M | $48.0M | ||
| Q1 24 | $18.7M | $47.4M |
股东权益ASMBFORA
| Q4 25 | — | $29.8M | ||
| Q3 25 | $182.7M | $31.1M | ||
| Q2 25 | $18.1M | $30.9M | ||
| Q1 25 | $27.1M | $30.0M | ||
| Q4 24 | $33.4M | $30.1M | ||
| Q3 24 | $26.0M | $28.4M | ||
| Q2 24 | $34.7M | $27.2M | ||
| Q1 24 | $32.6M | $28.1M |
总资产ASMBFORA
| Q4 25 | — | $44.1M | ||
| Q3 25 | $240.0M | $41.3M | ||
| Q2 25 | $80.8M | $48.5M | ||
| Q1 25 | $99.0M | $48.6M | ||
| Q4 24 | $119.2M | $47.2M | ||
| Q3 24 | $100.3M | $57.5M | ||
| Q2 24 | $115.3M | $58.4M | ||
| Q1 24 | $119.9M | $57.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBFORA
| Q4 25 | — | $3.2M | ||
| Q3 25 | $-15.1M | $-439.7K | ||
| Q2 25 | $-16.8M | $-344.5K | ||
| Q1 25 | $-23.4M | $448.2K | ||
| Q4 24 | $-51.1M | $1.7M | ||
| Q3 24 | $-15.2M | $764.1K | ||
| Q2 24 | $-17.1M | $-23.1K | ||
| Q1 24 | $-18.4M | $-2.2M |
自由现金流ASMBFORA
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-17.1M | — | ||
| Q1 24 | $-18.4M | — |
自由现金流率ASMBFORA
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -200.6% | — | ||
| Q1 24 | -317.7% | — |
资本支出强度ASMBFORA
| Q4 25 | — | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率ASMBFORA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.53× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 8.76× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
FORA
| Financial Services Revenues | $7.3M | 92% |
| Other | $669.0K | 8% |
